Loss of ambulation in SMA III at the time of disease-modifying treatments: an international study.
Coratti G, Bovis F, Franchino V, Montes J, Sansone VA, Dunaway Young S, Cutrì C, Pasternak A, Pera MC, Pane M, Glanzman A, Pegoraro E, Duong T, Sogus E, Sframeli M, Messina S, Cavalcante E, Scoto MC, D'Amico A, Rodriguez-Torres R, Mongini T, Maggi L, Coccia M, Filosto M, Zuccarino R, Masson R, Ricci G, Bruno C, Ruggiero L, Vacchiano V, D'errico E, Verriello L, Nigro V, Scarpini G, Garibaldi M, Turri M, Ticci C, Berardinelli A, Agosto C, Ricci F, Zolkipli-Cunningham Z, Darras BT, Day J, Hirano M, Muntoni F, Finkel RS, Mercuri E; international SMA consortium (ISMAC).
Coratti G, et al.
J Neurol Neurosurg Psychiatry. 2026 Jan 30:jnnp-2025-337505. doi: 10.1136/jnnp-2025-337505. Online ahead of print.
J Neurol Neurosurg Psychiatry. 2026.
PMID: 41617535
Free article.